Poisoning by, adverse effect of and underdosing of topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinorlaryngological and dental drugs (T49)
Clinical Information
Acidosis, Lactic - Acidosis caused by accumulation of lactic acid more rapidly than it can be metabolized. It may occur spontaneously or in association with diseases such as DIABETES MELLITUS; LEUKEMIA; or LIVER FAILURE.
Allantoin - A urea hydantoin that is found in URINE and PLANTS and is used in dermatological preparations.
Aminacrine - A highly fluorescent anti-infective dye used clinically as a topical antiseptic and experimentally as a mutagen, due to its interaction with DNA. It is also used as an intracellular pH indicator.
Anacardic Acids - A group of 6-alkyl SALICYLIC ACIDS that are found in ANACARDIUM and known for causing CONTACT DERMATITIS.
Anthemis - A plant genus of the family ASTERACEAE that is similar to MATRICARIA but this has tiny chaffy bract scales between each pair of florets. Members contain sesquiterpene lactones. Other plants with similar common names include FERULA; FOENICULUM; MATRICARIA; CHAMAEMELUM and TRIPLEUROSPERMUM.
Anthralin - An anthracene derivative that disrupts function and structure of MITOCHONDRIA and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
Antidepressive Agents - Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.
Antipruritics - Agents, usually topical, that relieve itching (pruritus).
Arylsulfotransferase - A sulfotransferase that catalyzes the sulfation of a phenol in the presence of 3'-phosphoadenylylsulfate as sulfate donor to yield an aryl sulfate and adenosine 3',5'-bisphosphate. A number of aromatic compounds can act as acceptors; however, organic hydroxylamines are not substrates. Sulfate conjugation by this enzyme is a major pathway for the biotransformation of phenolic and catechol drugs as well as neurotransmitters. EC 2.8.2.1.
Bentonite - A colloidal, hydrated aluminum silicate that swells 12 times its dry size when added to water.
Benzoates - Derivatives of BENZOIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxybenzene structure.
Benzoic Acid - A fungistatic compound that is widely used as a food preservative. It is conjugated to GLYCINE in the liver and excreted as hippuric acid.
Benzophenones - Derivatives of benzophenone (with the structural formula phenyl-(C=O)-phenyl).
Benzoyl Peroxide - A peroxide derivative that has been used topically for BURNS and as a dermatologic agent in the treatment of ACNE and POISON IVY DERMATITIS. It is used also as a bleach in the food industry.
Benzydamine - A benzyl-indazole having analgesic, antipyretic, and anti-inflammatory effects. It is used to reduce post-surgical and post-traumatic pain and edema and to promote healing. It is also used topically in treatment of RHEUMATIC DISEASES and INFLAMMATION of the mouth and throat.
Betamethasone - A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724)
Betamethasone Valerate - The 17-valerate derivative of BETAMETHASONE. It has substantial topical anti-inflammatory activity and relatively low systemic anti-inflammatory activity.
Candicidin - Mixture of antifungal heptaene macrolides from Streptomyces griseus or Actinomyces levoris used topically in candidiasis. The antibiotic complex is composed of candicidins A, B, C, and D, of which D is the major component.
Capsaicin - An alkylamide found in CAPSICUM that acts at TRPV CATION CHANNELS.
Capsicum - A plant genus of the family SOLANACEAE. The hot peppers yield CAPSAICIN, which activates VANILLOID RECEPTORS. Several varieties have sweet or pungent edible fruits that are used as vegetables when fresh and spices when the pods are dried.
Carps - Common name for a number of different species of fish in the family Cyprinidae. This includes, among others, the common carp, crucian carp, grass carp, and silver carp.
Chamaemelum - A plant genus of the family ASTERACEAE that is used in folk medicine as CHAMOMILE. Other plants with similar common names include MATRICARIA; TRIPLEUROSPERMUM and ANTHEMIS.
Chamomile - Common name for several daisy-like plants (MATRICARIA; TRIPLEUROSPERMUM; ANTHEMIS; CHAMAEMELUM) native to Europe and Western Asia, now naturalized in the United States and Australia.
Chlorhexidine - A disinfectant and topical anti-infective agent used also as mouthwash to prevent oral plaque.
Chlorobutanol - A colorless to white crystalline compound with a camphoraceous odor and taste. It is a widely used preservative in various pharmaceutical solutions, especially injectables. Also, it is an active ingredient in certain oral sedatives and topical anesthetics.
Chlorquinaldol - Local anti-infective agent used for skin, gastrointestinal, and vaginal infections with fungi, protozoa, and certain bacteria. In animals, it causes central nervous system damage and is not administered parenterally. It is also used as antiseptic, fungistat, or deodorant.
Clobetasol - A derivative of PREDNISOLONE with high glucocorticoid activity and low mineralocorticoid activity. Absorbed through the skin faster than FLUOCINONIDE, it is used topically in treatment of PSORIASIS but may cause marked adrenocortical suppression.
Clotrimazole - An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal CELL MEMBRANES. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane.
Collodion - A nitrocellulose solution in ether and alcohol. Collodion has a wide range of uses in industry including applications in the manufacture of photographic film, in fibers, in lacquers, and in engraving and lithography. In medicine it is used as a drug solvent and a wound sealant.
Cosmetics - Substances intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, or altering the appearance without affecting the body's structure or functions. Included in this definition are skin creams, lotions, perfumes, lipsticks, fingernail polishes, eye and facial makeup preparations, permanent waves, hair colors, toothpastes, and deodorants, as well as any material intended for use as a component of a cosmetic product. (U.S. Food & Drug Administration Center for Food Safety & Applied Nutrition Office of Cosmetics Fact Sheet (web page) Feb 1995)
Cottonseed Oil - Oil obtained from the seeds of Gossypium herbaceum L., the cotton plant. It is used in dietary products such as oleomargarine and many cooking oils. Cottonseed oil is commonly used in soaps and cosmetics.
Desonide - A nonfluorinated corticosteroid anti-inflammatory agent used topically for DERMATOSES.
Desoximetasone - A topical anti-inflammatory glucocorticoid used in DERMATOSES, skin allergies, PSORIASIS, etc.
Diatrizoate - A commonly used x-ray contrast medium. As DIATRIZOATE MEGLUMINE and as Diatrizoate sodium, it is used for gastrointestinal studies, angiography, and urography.
Diflucortolone - A topical glucocorticoid used in various DERMATOSES. It is absorbed through the skin, bound to plasma albumin, and may cause adrenal suppression. It is also administered as the valerate.
Econazole - An imidazole derivative that is commonly used as a topical antifungal agent.
Ethacridine - A topically applied anti-infective agent.
Eucalyptus Oil - An oily liquid that is extracted from the leaves of EUCALYPTUS trees.
Eugenol - A cinnamate derivative of the shikimate pathway found in CLOVE OIL and other PLANTS.
Flumethasone - An anti-inflammatory glucocorticoid used in veterinary practice.
Fluocinonide - A topical glucocorticoid used in the treatment of ECZEMA.
Fluocortolone - A glucocorticoid with anti-inflammatory activity used topically for various skin disorders.
Fluorometholone - A glucocorticoid employed, usually as eye drops, in the treatment of allergic and inflammatory conditions of the eye. It has also been used topically in the treatment of various skin disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732)
Flurandrenolone - A corticosteroid used topically in the treatment of various skin disorders. It is usually employed as a cream or an ointment, and is also used as a polyethylene tape with an adhesive. (From Martindale, The Extra Pharmacopoeia, 30th ed, p733)
Fusidic Acid - An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed). It acts by inhibiting translocation during protein synthesis.
gp100 Melanoma Antigen - A melanosome-associated protein that plays a role in the maturation of the MELANOSOME.
Gramicidin - A group of peptide antibiotics from BACILLUS brevis. Gramicidin C or S is a cyclic, ten-amino acid polypeptide and gramicidins A, B, D are linear. Gramicidin is one of the two principal components of TYROTHRICIN.
Hair Preparations - Hair grooming, cleansing and modifying products meant for topical application to hair, usually human. They include sprays, bleaches, dyes, conditioners, rinses, shampoos, nutrient lotions, etc.
Halcinonide - A glucocorticoid used topically in the treatment of DERMATITIS; ECZEMA; or PSORIASIS. It may cause skin irritation.
Hamamelis - A plant genus of the family Hamamelidaceae, order Hamamelidales. It is known for the astringent (ASTRINGENTS) extract of leaves and bark used in over the counter preparations. This should not be confused with the similar named Hamelia genus (RUBIACEAE).
Hexachlorophene - A chlorinated bisphenol antiseptic with a bacteriostatic action against Gram-positive organisms, but much less effective against Gram-negative organisms. It is mainly used in soaps and creams and is an ingredient of various preparations used for skin disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p797)
Hydrolyzable Tannins - Polymeric derivatives of GALLIC ACID that are esters of a sugar.
Ichthyosis, Lamellar - A chronic, congenital ichthyosis inherited as an autosomal recessive trait. Infants are usually born encased in a collodion membrane which sheds within a few weeks. Scaling is generalized and marked with grayish-brown quadrilateral scales, adherent at their centers and free at the edges. In some cases, scales are so thick that they resemble armored plate.
Ketoconazole - Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients.
Lactic Acid - A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
Lactobacillales - An order of gram-positive bacteria in the class Bacilli, that have the ability to ferment sugars to lactic acid. They are widespread in nature and commonly used to produce FERMENTED FOODS.
Lanolin - A yellow fat obtained from sheep's wool. It is used as an emollient, cosmetic, and pharmaceutic aid.
Lepisma - A small nocturnal wingless insect with tapering physical outline.
Levobunolol - The L-Isomer of bunolol.
Mafenide - A sulfonamide that inhibits the enzyme CARBONIC ANHYDRASE and is used as a topical anti-bacterial agent, especially in burn therapy.
Matricaria - A plant genus of the family ASTERACEAE. M. chamomilla appears similar to Anthemis but this flower disk is conical and hollow and lacks chaffy bract scales and the odor is weaker. The common name of 'manzanilla' is confused with other meanings of the word. 'Matricaria chamomilla sensu' is classified by some as Tripleurospermum perforata. Other plants with similar common names include CHAMAEMELUM; TRIPLEUROSPERMUM and ANTHEMIS.
Meclofenamic Acid - A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
Merbromin - A once-popular mercury containing topical antiseptic.
Methenamine - An anti-infective agent most commonly used in the treatment of urinary tract infections. Its anti-infective action derives from the slow release of formaldehyde by hydrolysis at acidic pH. (From Martindale, The Extra Pharmacopoeia, 30th ed, p173)
Metipranolol - A beta-adrenergic antagonist effective for both beta-1 and beta-2 receptors. It is used as an antiarrhythmic, antihypertensive, and antiglaucoma agent.
Metrizoic Acid - A diagnostic radiopaque that usually occurs as the sodium salt.
Miconazole - An imidazole antifungal agent that is used topically and by intravenous infusion.
Mineral Oil - A mixture of liquid hydrocarbons obtained from petroleum. It is used as laxative, lubricant, ointment base, and emollient.
Monophenol Monooxygenase - An enzyme of the oxidoreductase class that catalyzes the reaction between L-tyrosine, L-dopa, and oxygen to yield L-dopa, dopaquinone, and water. It is a copper protein that acts also on catechols, catalyzing some of the same reactions as CATECHOL OXIDASE. EC 1.14.18.1.
Mupirocin - A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing.
Natamycin - Amphoteric macrolide antifungal antibiotic from Streptomyces natalensis or S. chattanoogensis. It is used for a variety of fungal infections, mainly topically.
Nitrofurazone - A topical anti-infective agent effective against gram-negative and gram-positive bacteria. It is used for superficial WOUNDS AND INJURIES and skin infections. Nitrofurazone has also been administered orally in the treatment of TRYPANOSOMIASIS.
Oncorhynchus kisutch - An anadromous species of SALMON ranging from the Arctic and Pacific Oceans to Monterey Bay, California and inhabiting ocean and coastal streams. It is familiarly known as the coho or silver salmon. It is relatively small but its light-colored flesh is of good flavor.
Oxyphenisatin Acetate - A laxative that undergoes enterohepatic circulation. It may cause jaundice.
Pefloxacin - A synthetic broad-spectrum fluoroquinolone antibacterial agent active against most gram-negative and gram-positive bacteria.
Petrolatum - A colloidal system of semisolid hydrocarbons obtained from PETROLEUM. It is used as an ointment base, topical protectant, and lubricant.
Phenol - An antiseptic and disinfectant aromatic alcohol.
Phenolphthalein - An acid-base indicator which is colorless in acid solution, but turns pink to red as the solution becomes alkaline. It is used medicinally as a cathartic.
Phenolphthaleins - A family of 3,3-bis(p-hydroxyphenyl)phthalides. They are used as CATHARTICS, indicators, and COLORING AGENTS.
Phenols - Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
Phenolsulfonphthalein - Red dye, pH indicator, and diagnostic aid for determination of renal function. It is used also for studies of the gastrointestinal and other systems.
Physostigmine - A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity.
Plastocyanin - A copper-containing plant protein that is a fundamental link in the electron transport chain of green plants during the photosynthetic conversion of light energy by photophosphorylation into the potential energy of chemical bonds.
Podophyllotoxin - A lignan (LIGNANS) found in PODOPHYLLIN resin from the roots of PODOPHYLLUM plants. It is a potent spindle poison, toxic if taken internally, and has been used as a cathartic. It is very irritating to skin and mucous membranes, has keratolytic actions, has been used to treat warts and keratoses, and may have antineoplastic properties, as do some of its congeners and derivatives.
Potentilla - A plant genus of the family ROSACEAE. Members contain procyanidins and TANNINS.
Proflavine - Topical antiseptic used mainly in wound dressings.
Propiolactone - Disinfectant used in vapor form to sterilize vaccines, grafts, etc. The vapor is very irritating and the liquid form is carcinogenic.
Pyrogallol - A trihydroxybenzene or dihydroxy phenol that can be prepared by heating GALLIC ACID.
Pyruvate Carboxylase Deficiency Disease - An autosomal recessive metabolic disorder caused by absent or decreased PYRUVATE CARBOXYLASE activity, the enzyme that regulates gluconeogenesis, lipogenesis, and neurotransmitter synthesis. Clinical manifestations include lactic acidosis, seizures, respiratory distress, marked psychomotor delay, periodic HYPOGLYCEMIA, and hypotonia. The clinical course may be similar to LEIGH DISEASE. (From Am J Hum Genet 1998 Jun;62(6):1312-9)
Pyruvate Dehydrogenase Complex Deficiency Disease - An inherited metabolic disorder caused by deficient enzyme activity in the PYRUVATE DEHYDROGENASE COMPLEX, resulting in deficiency of acetyl CoA and reduced synthesis of acetylcholine. Two clinical forms are recognized: neonatal and juvenile. The neonatal form is a relatively common cause of lactic acidosis in the first weeks of life and may also feature an erythematous rash. The juvenile form presents with lactic acidosis, alopecia, intermittent ATAXIA; SEIZURES; and an erythematous rash. (From J Inherit Metab Dis 1996;19(4):452-62) Autosomal recessive and X-linked forms are caused by mutations in the genes for the three different enzyme components of this multisubunit pyruvate dehydrogenase complex. One of the mutations at Xp22.2-p22.1 in the gene for the E1 alpha component of the complex leads to LEIGH DISEASE.
Salicylates - The salts or esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis.
Salicylic Acid - A compound obtained from the bark of the white willow and wintergreen leaves. It has bacteriostatic, fungicidal, and keratolytic actions.
Silver - An element with the atomic symbol Ag, atomic number 47, and atomic weight 107.87. It is a soft metal that is used medically in surgical instruments, dental prostheses, and alloys. Long-continued use of silver salts can lead to a form of poisoning known as ARGYRIA.
Silver Compounds - Inorganic compounds that contain silver as an integral part of the molecule.
Silver Nitrate - A silver salt with powerful germicidal activity. It has been used topically to prevent OPHTHALMIA NEONATORUM.
Silver Proteins - Compounds of silver and proteins used as topical anti-infective agents.
Silver Staining - The use of silver, usually silver nitrate, as a reagent for producing contrast or coloration in tissue specimens.
Silver Sulfadiazine - Antibacterial used topically in burn therapy.
Silver-Russell Syndrome - Genetically and clinically heterogeneous disorder characterized by low birth weight, postnatal growth retardation, facial dysmorphism, bilateral body asymmetry, and clinodactyly of the fifth fingers. Alterations in GENETIC IMPRINTING are involved. Hypomethylation of IGF2/H19 locus near an imprinting center region of chromosome 11p15 plays a role in a subset of Silver-Russell syndrome. Hypermethylation of the same chromosomal region, on the other hand, can cause BECKWITH-WIEDEMANN SYNDROME. Maternal UNIPARENTAL DISOMY for chromosome 7 is known to play a role in its etiology.
Sulfacetamide - An anti-bacterial agent that is used topically to treat skin infections and orally for urinary tract infections.
Thimerosal - An ethylmercury-sulfidobenzoate that has been used as a preservative in VACCINES; ANTIVENINS; and OINTMENTS. It was formerly used as a topical antiseptic. It degrades to ethylmercury and thiosalicylate.
Thymol - A phenol obtained from thyme oil or other volatile oils used as a stabilizer in pharmaceutical preparations, and as an antiseptic (antibacterial or antifungal) agent.
Thymolphthalein - Used as a pH indicator and as a reagent for blood after decolorizing the alkaline solution by boiling with zinc dust.
Tolnaftate - A synthetic antifungal agent.
Tretinoin - An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE).
Triacetin - A triglyceride that is used as an antifungal agent.
Triclosan - A diphenyl ether derivative used in cosmetics and toilet soaps as an antiseptic. It has some bacteriostatic and fungistatic action.
Tripleurospermum - A plant genus of the family ASTERACEAE. It is easily confused with related plants with similar common names of Chamomile and Mayweed (MATRICARIA; CHAMAEMELUM; and ANTHEMIS).
Tyrosine Phenol-Lyase - An enzyme that catalyzes the cleavage of tyrosine to phenol, pyruvate, and ammonia. It is a pyridoxal phosphate protein. The enzyme also forms pyruvate from D-tyrosine, L-cysteine, S-methyl-L-cysteine, L-serine, and D-serine, although at a slower rate. EC 4.1.99.2.
Tyrothricin - A polypeptide antibiotic mixture obtained from Bacillus brevis. It consists of a mixture of three tyrocidines (60%) and several gramicidins (20%) and is very toxic to blood, liver, kidneys, meninges, and the olfactory apparatus. It is used topically.
Instructional Notations
Includes
This note appears immediately under a three character code title to further define, or give examples of, the content of the category.
- poisoning by, adverse effect of and underdosing of glucocorticoids, topically used
7th Character Note
Certain ICD-10-CM categories have applicable 7th characters. The applicable 7th character is required for all codes within the category, or as the notes in the Tabular List instruct. The 7th character must always be the 7th character in the data field. If a code that requires a 7th character is not 6 characters, a placeholder X must be used to fill in the empty characters.
- The appropriate 7th character is to be added to each code from category T49
7th Character
Indicates that a seventh character is to be assigned to codes in a subcategory.
- A - initial encounter
- D - subsequent encounter
- S - sequela
Injury, poisoning and certain other consequences of external causes (S00–T88)
Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50)
T49 Poisoning by, adverse effect of and underdosing of topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinorlaryngological and dental drugs
T49.0 Poisoning by, adverse effect of and underdosing of local antifungal, anti-infective and anti-inflammatory drugs
T49.0X Poisoning by, adverse effect of and underdosing of local antifungal, anti-infective and anti-inflammatory drugs
T49.0X1 Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, accidental (unintentional)
- T49.0X1A Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, accidental (unintentional), initial encounter
- T49.0X1D Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, accidental (unintentional), subsequent encounter
- T49.0X1S Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, accidental (unintentional), sequela
T49.0X2 Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, intentional self-harm
- T49.0X2A Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, intentional self-harm, initial encounter
- T49.0X2D Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, intentional self-harm, subsequent encounter
- T49.0X2S Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, intentional self-harm, sequela
T49.0X3 Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, assault
- T49.0X3A Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, assault, initial encounter
- T49.0X3D Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, assault, subsequent encounter
- T49.0X3S Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, assault, sequela
T49.0X4 Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, undetermined
- T49.0X4A Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, undetermined, initial encounter
- T49.0X4D Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, undetermined, subsequent encounter
- T49.0X4S Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, undetermined, sequela
T49.0X5 Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs
- T49.0X5A Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
- T49.0X5D Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter
- T49.0X5S Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela
T49.0X6 Underdosing of local antifungal, anti-infective and anti-inflammatory drugs
- T49.0X6A Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
- T49.0X6D Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter
- T49.0X6S Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, sequela
T49.1 Poisoning by, adverse effect of and underdosing of antipruritics
T49.1X Poisoning by, adverse effect of and underdosing of antipruritics
T49.1X1 Poisoning by antipruritics, accidental (unintentional)
- T49.1X1A Poisoning by antipruritics, accidental (unintentional), initial encounter
- T49.1X1D Poisoning by antipruritics, accidental (unintentional), subsequent encounter
- T49.1X1S Poisoning by antipruritics, accidental (unintentional), sequela
T49.1X2 Poisoning by antipruritics, intentional self-harm
- T49.1X2A Poisoning by antipruritics, intentional self-harm, initial encounter
- T49.1X2D Poisoning by antipruritics, intentional self-harm, subsequent encounter
- T49.1X2S Poisoning by antipruritics, intentional self-harm, sequela
T49.1X3 Poisoning by antipruritics, assault
- T49.1X3A Poisoning by antipruritics, assault, initial encounter
- T49.1X3D Poisoning by antipruritics, assault, subsequent encounter
- T49.1X3S Poisoning by antipruritics, assault, sequela
T49.1X4 Poisoning by antipruritics, undetermined
- T49.1X4A Poisoning by antipruritics, undetermined, initial encounter
- T49.1X4D Poisoning by antipruritics, undetermined, subsequent encounter
- T49.1X4S Poisoning by antipruritics, undetermined, sequela
T49.1X5 Adverse effect of antipruritics
- T49.1X5A Adverse effect of antipruritics, initial encounter
- T49.1X5D Adverse effect of antipruritics, subsequent encounter
- T49.1X5S Adverse effect of antipruritics, sequela
T49.1X6 Underdosing of antipruritics
- T49.1X6A Underdosing of antipruritics, initial encounter
- T49.1X6D Underdosing of antipruritics, subsequent encounter
- T49.1X6S Underdosing of antipruritics, sequela
T49.2 Poisoning by, adverse effect of and underdosing of local astringents and local detergents
T49.2X Poisoning by, adverse effect of and underdosing of local astringents and local detergents
T49.2X1 Poisoning by local astringents and local detergents, accidental (unintentional)
- T49.2X1A Poisoning by local astringents and local detergents, accidental (unintentional), initial encounter
- T49.2X1D Poisoning by local astringents and local detergents, accidental (unintentional), subsequent encounter
- T49.2X1S Poisoning by local astringents and local detergents, accidental (unintentional), sequela
T49.2X2 Poisoning by local astringents and local detergents, intentional self-harm
- T49.2X2A Poisoning by local astringents and local detergents, intentional self-harm, initial encounter
- T49.2X2D Poisoning by local astringents and local detergents, intentional self-harm, subsequent encounter
- T49.2X2S Poisoning by local astringents and local detergents, intentional self-harm, sequela
T49.2X3 Poisoning by local astringents and local detergents, assault
- T49.2X3A Poisoning by local astringents and local detergents, assault, initial encounter
- T49.2X3D Poisoning by local astringents and local detergents, assault, subsequent encounter
- T49.2X3S Poisoning by local astringents and local detergents, assault, sequela
T49.2X4 Poisoning by local astringents and local detergents, undetermined
- T49.2X4A Poisoning by local astringents and local detergents, undetermined, initial encounter
- T49.2X4D Poisoning by local astringents and local detergents, undetermined, subsequent encounter
- T49.2X4S Poisoning by local astringents and local detergents, undetermined, sequela
T49.2X5 Adverse effect of local astringents and local detergents
- T49.2X5A Adverse effect of local astringents and local detergents, initial encounter
- T49.2X5D Adverse effect of local astringents and local detergents, subsequent encounter
- T49.2X5S Adverse effect of local astringents and local detergents, sequela
T49.2X6 Underdosing of local astringents and local detergents
- T49.2X6A Underdosing of local astringents and local detergents, initial encounter
- T49.2X6D Underdosing of local astringents and local detergents, subsequent encounter
- T49.2X6S Underdosing of local astringents and local detergents, sequela
T49.3 Poisoning by, adverse effect of and underdosing of emollients, demulcents and protectants
T49.3X Poisoning by, adverse effect of and underdosing of emollients, demulcents and protectants
T49.3X1 Poisoning by emollients, demulcents and protectants, accidental (unintentional)
- T49.3X1A Poisoning by emollients, demulcents and protectants, accidental (unintentional), initial encounter
- T49.3X1D Poisoning by emollients, demulcents and protectants, accidental (unintentional), subsequent encounter
- T49.3X1S Poisoning by emollients, demulcents and protectants, accidental (unintentional), sequela
T49.3X2 Poisoning by emollients, demulcents and protectants, intentional self-harm
- T49.3X2A Poisoning by emollients, demulcents and protectants, intentional self-harm, initial encounter
- T49.3X2D Poisoning by emollients, demulcents and protectants, intentional self-harm, subsequent encounter
- T49.3X2S Poisoning by emollients, demulcents and protectants, intentional self-harm, sequela
T49.3X3 Poisoning by emollients, demulcents and protectants, assault
- T49.3X3A Poisoning by emollients, demulcents and protectants, assault, initial encounter
- T49.3X3D Poisoning by emollients, demulcents and protectants, assault, subsequent encounter
- T49.3X3S Poisoning by emollients, demulcents and protectants, assault, sequela
T49.3X4 Poisoning by emollients, demulcents and protectants, undetermined
- T49.3X4A Poisoning by emollients, demulcents and protectants, undetermined, initial encounter
- T49.3X4D Poisoning by emollients, demulcents and protectants, undetermined, subsequent encounter
- T49.3X4S Poisoning by emollients, demulcents and protectants, undetermined, sequela
T49.3X5 Adverse effect of emollients, demulcents and protectants
- T49.3X5A Adverse effect of emollients, demulcents and protectants, initial encounter
- T49.3X5D Adverse effect of emollients, demulcents and protectants, subsequent encounter
- T49.3X5S Adverse effect of emollients, demulcents and protectants, sequela
T49.3X6 Underdosing of emollients, demulcents and protectants
- T49.3X6A Underdosing of emollients, demulcents and protectants, initial encounter
- T49.3X6D Underdosing of emollients, demulcents and protectants, subsequent encounter
- T49.3X6S Underdosing of emollients, demulcents and protectants, sequela
T49.4 Poisoning by, adverse effect of and underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations
T49.4X Poisoning by, adverse effect of and underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations
T49.4X1 Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, accidental (unintentional)
- T49.4X1A Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, accidental (unintentional), initial encounter
- T49.4X1D Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, accidental (unintentional), subsequent encounter
- T49.4X1S Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, accidental (unintentional), sequela
T49.4X2 Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, intentional self-harm
- T49.4X2A Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, intentional self-harm, initial encounter
- T49.4X2D Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, intentional self-harm, subsequent encounter
- T49.4X2S Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, intentional self-harm, sequela
T49.4X3 Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, assault
- T49.4X3A Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, assault, initial encounter
- T49.4X3D Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, assault, subsequent encounter
- T49.4X3S Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, assault, sequela
T49.4X4 Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, undetermined
- T49.4X4A Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, undetermined, initial encounter
- T49.4X4D Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, undetermined, subsequent encounter
- T49.4X4S Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, undetermined, sequela
T49.4X5 Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations
- T49.4X5A Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
- T49.4X5D Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter
- T49.4X5S Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela
T49.4X6 Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations
- T49.4X6A Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
- T49.4X6D Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter
- T49.4X6S Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela
T49.5 Poisoning by, adverse effect of and underdosing of ophthalmological drugs and preparations
T49.5X Poisoning by, adverse effect of and underdosing of ophthalmological drugs and preparations
T49.5X1 Poisoning by ophthalmological drugs and preparations, accidental (unintentional)
- T49.5X1A Poisoning by ophthalmological drugs and preparations, accidental (unintentional), initial encounter
- T49.5X1D Poisoning by ophthalmological drugs and preparations, accidental (unintentional), subsequent encounter
- T49.5X1S Poisoning by ophthalmological drugs and preparations, accidental (unintentional), sequela
T49.5X2 Poisoning by ophthalmological drugs and preparations, intentional self-harm
- T49.5X2A Poisoning by ophthalmological drugs and preparations, intentional self-harm, initial encounter
- T49.5X2D Poisoning by ophthalmological drugs and preparations, intentional self-harm, subsequent encounter
- T49.5X2S Poisoning by ophthalmological drugs and preparations, intentional self-harm, sequela
T49.5X3 Poisoning by ophthalmological drugs and preparations, assault
- T49.5X3A Poisoning by ophthalmological drugs and preparations, assault, initial encounter
- T49.5X3D Poisoning by ophthalmological drugs and preparations, assault, subsequent encounter
- T49.5X3S Poisoning by ophthalmological drugs and preparations, assault, sequela
T49.5X4 Poisoning by ophthalmological drugs and preparations, undetermined
- T49.5X4A Poisoning by ophthalmological drugs and preparations, undetermined, initial encounter
- T49.5X4D Poisoning by ophthalmological drugs and preparations, undetermined, subsequent encounter
- T49.5X4S Poisoning by ophthalmological drugs and preparations, undetermined, sequela
T49.5X5 Adverse effect of ophthalmological drugs and preparations
- T49.5X5A Adverse effect of ophthalmological drugs and preparations, initial encounter
- T49.5X5D Adverse effect of ophthalmological drugs and preparations, subsequent encounter
- T49.5X5S Adverse effect of ophthalmological drugs and preparations, sequela
T49.5X6 Underdosing of ophthalmological drugs and preparations
- T49.5X6A Underdosing of ophthalmological drugs and preparations, initial encounter
- T49.5X6D Underdosing of ophthalmological drugs and preparations, subsequent encounter
- T49.5X6S Underdosing of ophthalmological drugs and preparations, sequela
T49.6 Poisoning by, adverse effect of and underdosing of otorhinolaryngological drugs and preparations
T49.6X Poisoning by, adverse effect of and underdosing of otorhinolaryngological drugs and preparations
T49.6X1 Poisoning by otorhinolaryngological drugs and preparations, accidental (unintentional)
- T49.6X1A Poisoning by otorhinolaryngological drugs and preparations, accidental (unintentional), initial encounter
- T49.6X1D Poisoning by otorhinolaryngological drugs and preparations, accidental (unintentional), subsequent encounter
- T49.6X1S Poisoning by otorhinolaryngological drugs and preparations, accidental (unintentional), sequela
T49.6X2 Poisoning by otorhinolaryngological drugs and preparations, intentional self-harm
- T49.6X2A Poisoning by otorhinolaryngological drugs and preparations, intentional self-harm, initial encounter
- T49.6X2D Poisoning by otorhinolaryngological drugs and preparations, intentional self-harm, subsequent encounter
- T49.6X2S Poisoning by otorhinolaryngological drugs and preparations, intentional self-harm, sequela
T49.6X3 Poisoning by otorhinolaryngological drugs and preparations, assault
- T49.6X3A Poisoning by otorhinolaryngological drugs and preparations, assault, initial encounter
- T49.6X3D Poisoning by otorhinolaryngological drugs and preparations, assault, subsequent encounter
- T49.6X3S Poisoning by otorhinolaryngological drugs and preparations, assault, sequela
T49.6X4 Poisoning by otorhinolaryngological drugs and preparations, undetermined
- T49.6X4A Poisoning by otorhinolaryngological drugs and preparations, undetermined, initial encounter
- T49.6X4D Poisoning by otorhinolaryngological drugs and preparations, undetermined, subsequent encounter
- T49.6X4S Poisoning by otorhinolaryngological drugs and preparations, undetermined, sequela
T49.6X5 Adverse effect of otorhinolaryngological drugs and preparations
- T49.6X5A Adverse effect of otorhinolaryngological drugs and preparations, initial encounter
- T49.6X5D Adverse effect of otorhinolaryngological drugs and preparations, subsequent encounter
- T49.6X5S Adverse effect of otorhinolaryngological drugs and preparations, sequela
T49.6X6 Underdosing of otorhinolaryngological drugs and preparations
- T49.6X6A Underdosing of otorhinolaryngological drugs and preparations, initial encounter
- T49.6X6D Underdosing of otorhinolaryngological drugs and preparations, subsequent encounter
- T49.6X6S Underdosing of otorhinolaryngological drugs and preparations, sequela
T49.7 Poisoning by, adverse effect of and underdosing of dental drugs, topically applied
T49.7X Poisoning by, adverse effect of and underdosing of dental drugs, topically applied
T49.7X1 Poisoning by dental drugs, topically applied, accidental (unintentional)
- T49.7X1A Poisoning by dental drugs, topically applied, accidental (unintentional), initial encounter
- T49.7X1D Poisoning by dental drugs, topically applied, accidental (unintentional), subsequent encounter
- T49.7X1S Poisoning by dental drugs, topically applied, accidental (unintentional), sequela
T49.7X2 Poisoning by dental drugs, topically applied, intentional self-harm
- T49.7X2A Poisoning by dental drugs, topically applied, intentional self-harm, initial encounter
- T49.7X2D Poisoning by dental drugs, topically applied, intentional self-harm, subsequent encounter
- T49.7X2S Poisoning by dental drugs, topically applied, intentional self-harm, sequela
T49.7X3 Poisoning by dental drugs, topically applied, assault
- T49.7X3A Poisoning by dental drugs, topically applied, assault, initial encounter
- T49.7X3D Poisoning by dental drugs, topically applied, assault, subsequent encounter
- T49.7X3S Poisoning by dental drugs, topically applied, assault, sequela
T49.7X4 Poisoning by dental drugs, topically applied, undetermined
- T49.7X4A Poisoning by dental drugs, topically applied, undetermined, initial encounter
- T49.7X4D Poisoning by dental drugs, topically applied, undetermined, subsequent encounter
- T49.7X4S Poisoning by dental drugs, topically applied, undetermined, sequela
T49.7X5 Adverse effect of dental drugs, topically applied
- T49.7X5A Adverse effect of dental drugs, topically applied, initial encounter
- T49.7X5D Adverse effect of dental drugs, topically applied, subsequent encounter
- T49.7X5S Adverse effect of dental drugs, topically applied, sequela
T49.7X6 Underdosing of dental drugs, topically applied
- T49.7X6A Underdosing of dental drugs, topically applied, initial encounter
- T49.7X6D Underdosing of dental drugs, topically applied, subsequent encounter
- T49.7X6S Underdosing of dental drugs, topically applied, sequela
T49.8 Poisoning by, adverse effect of and underdosing of other topical agents
T49.8X Poisoning by, adverse effect of and underdosing of other topical agents
T49.8X1 Poisoning by other topical agents, accidental (unintentional)
- T49.8X1A Poisoning by other topical agents, accidental (unintentional), initial encounter
- T49.8X1D Poisoning by other topical agents, accidental (unintentional), subsequent encounter
- T49.8X1S Poisoning by other topical agents, accidental (unintentional), sequela
T49.8X2 Poisoning by other topical agents, intentional self-harm
- T49.8X2A Poisoning by other topical agents, intentional self-harm, initial encounter
- T49.8X2D Poisoning by other topical agents, intentional self-harm, subsequent encounter
- T49.8X2S Poisoning by other topical agents, intentional self-harm, sequela
T49.8X3 Poisoning by other topical agents, assault
- T49.8X3A Poisoning by other topical agents, assault, initial encounter
- T49.8X3D Poisoning by other topical agents, assault, subsequent encounter
- T49.8X3S Poisoning by other topical agents, assault, sequela
T49.8X4 Poisoning by other topical agents, undetermined
- T49.8X4A Poisoning by other topical agents, undetermined, initial encounter
- T49.8X4D Poisoning by other topical agents, undetermined, subsequent encounter
- T49.8X4S Poisoning by other topical agents, undetermined, sequela
T49.8X5 Adverse effect of other topical agents
- T49.8X5A Adverse effect of other topical agents, initial encounter
- T49.8X5D Adverse effect of other topical agents, subsequent encounter
- T49.8X5S Adverse effect of other topical agents, sequela
T49.8X6 Underdosing of other topical agents
- T49.8X6A Underdosing of other topical agents, initial encounter
- T49.8X6D Underdosing of other topical agents, subsequent encounter
- T49.8X6S Underdosing of other topical agents, sequela
T49.9 Poisoning by, adverse effect of and underdosing of unspecified topical agent
T49.91 Poisoning by unspecified topical agent, accidental (unintentional)
- T49.91XA Poisoning by unspecified topical agent, accidental (unintentional), initial encounter
- T49.91XD Poisoning by unspecified topical agent, accidental (unintentional), subsequent encounter
- T49.91XS Poisoning by unspecified topical agent, accidental (unintentional), sequela
T49.92 Poisoning by unspecified topical agent, intentional self-harm
- T49.92XA Poisoning by unspecified topical agent, intentional self-harm, initial encounter
- T49.92XD Poisoning by unspecified topical agent, intentional self-harm, subsequent encounter
- T49.92XS Poisoning by unspecified topical agent, intentional self-harm, sequela
T49.93 Poisoning by unspecified topical agent, assault
- T49.93XA Poisoning by unspecified topical agent, assault, initial encounter
- T49.93XD Poisoning by unspecified topical agent, assault, subsequent encounter
- T49.93XS Poisoning by unspecified topical agent, assault, sequela
T49.94 Poisoning by unspecified topical agent, undetermined
- T49.94XA Poisoning by unspecified topical agent, undetermined, initial encounter
- T49.94XD Poisoning by unspecified topical agent, undetermined, subsequent encounter
- T49.94XS Poisoning by unspecified topical agent, undetermined, sequela
T49.95 Adverse effect of unspecified topical agent
- T49.95XA Adverse effect of unspecified topical agent, initial encounter
- T49.95XD Adverse effect of unspecified topical agent, subsequent encounter
- T49.95XS Adverse effect of unspecified topical agent, sequela
T49.96 Underdosing of unspecified topical agent
- T49.96XA Underdosing of unspecified topical agent, initial encounter
- T49.96XD Underdosing of unspecified topical agent, subsequent encounter
- T49.96XS Underdosing of unspecified topical agent, sequela
Poisoning by, adverse effect of and underdosing of topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinorlaryngological and dental drugs (T49)